can glp 1 cause migraines Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review | The Journal of Headache and Pain GLP-1 Drug Cuts Migraine Days

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD) Status: Recruiting This study is a randomized controlled trial of oral semaglutide among treatment-seeking individuals with AUD

L karnitin kullanm konusunda bireylerin en ok dikkat etmesi gereken nokta, bu bileenin vcudun genel biyokimyasal dengesiyle uyumlu ekilde planlanmasdr

Pharmacologic approaches to glycemic treatment: standards of medical Care in diabetes2021

Even though a promising candidate for lifespan extension and SASP repression, multiple side effects including metabolic dysregulation, impaired wound healing, and hyperlipidemia have been reported (85)

As chronic diseases rise globally, pharmaceutical companies are aligning their research and development initiatives with the World Health Organization's recommendations to combat non-communicable diseases